Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Coastal Acquisition II A | ACAB | Nov 14, 2024 | 5.77 | 0.00 |
Atlantic Union Bank | AUB | Nov 14, 2024 | 42.65 | +0.21 |
Atlantic Union Bankshares A Pref | AUB-A | Nov 14, 2024 | 25.83 | +0.05 |
Atlantica Sustainable Infrastructure | AY | Nov 14, 2024 | 22.10 | 0.00 |
Atlanticus | ATLC | Nov 14, 2024 | 49.20 | +6.54 |
Atlanticus B Pref | ATLCP | Nov 14, 2024 | 23.73 | -0.13 |
Atlas Energy Solutions | AESI | Nov 14, 2024 | 20.25 | -4.12 |
Atlas Lithium | ATLX | Nov 14, 2024 | 7.82 | -2.13 |
Atlas Pref D | ATCO-D | Nov 14, 2024 | 25.06 | +0.04 |
Atlas Pref H | ATCO-H | Nov 14, 2024 | 25.10 | +0.40 |
AtlasClear Holdings | ATCH | Nov 14, 2024 | 0.19 | +3.35 |
Atlassian A | TEAM | Nov 14, 2024 | 249.99 | -1.10 |
Atmos Energy | ATO | Nov 14, 2024 | 144.34 | -1.48 |
Atmus Filtration Technologies | ATMU | Nov 14, 2024 | 43.10 | -1.08 |
ATN International | ATNI | Nov 14, 2024 | 19.34 | -1.33 |
Atomera | ATOM | Nov 14, 2024 | 5.94 | -6.46 |
Atossa Therapeutics | ATOS | Nov 14, 2024 | 1.37 | 0.00 |
Atour Lifestyle ADR | ATAT | Nov 14, 2024 | 26.11 | -2.03 |
ATRenew A ADR | RERE | Nov 14, 2024 | 2.38 | -1.24 |
AtriCure | ATRC | Nov 14, 2024 | 35.31 | -2.46 |
ATS Corporation | ATS | Nov 14, 2024 | 28.76 | -2.01 |
aTyr Pharma | ATYR | Nov 14, 2024 | 3.19 | -9.38 |
Auburn National Bank | AUBN | Nov 14, 2024 | 22.00 | +1.85 |
Auddia | AUUD | Nov 14, 2024 | 0.56 | +1.00 |
AudioCodes | AUDC | Nov 14, 2024 | 8.35 | -0.71 |
AudioEye | AEYE | Nov 14, 2024 | 26.16 | -1.02 |
Ault Disruptive Technologies SPAC | ADRT | Nov 14, 2024 | 11.40 | 0.00 |
Auna S.A.A | AUNA | Nov 14, 2024 | 7.17 | +2.72 |
Aura Biosciences | AURA | Nov 14, 2024 | 9.97 | -3.49 |
Aura FAT Projects Acquisition A | AFAR | Nov 14, 2024 | 11.68 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.